PBLA Panbela Therapeutics
- 0.375
- +0.046+13.95%
Panbela Therapeutics News
Panbela Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Panbela Therapeutics | 8-K: Current report
Panbela Therapeutics | 8-K: Current report
Panbela Therapeutics | 8-K: Current report
Panbela Therapeutics | 8-K: Current report
Panbela Therapeutics | 8-K: Current report
Panbela Therapeutics | DEFR14A: Definitive proxy statement in connection with contested solicitations
Panbela Therapeutics | DEFA14A: Others
Panbela Therapeutics | 8-K: Current report
Panbela Therapeutics | 8-K: Current report
Panbela Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Panbela Therapeutics | 8-K: Current report
Panbela Therapeutics | DEF 14A: Definitive information statements
Panbela Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Panbela Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Panbela Therapeutics | 8-K: Current report
Panbela Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Panbela Therapeutics | 8-K: Current report
Panbela Therapeutics | 8-K: Current report
Panbela Therapeutics | 8-K: Current report
Analysis
Price Target
No Data
